Erythema Nodosum Associated with Terbinafine Therapy- A Case Report
Journal Title: Journal of Dermatology Research - Year 2023, Vol 4, Issue 1
Abstract
Terbinafine is a commonly used anti-fungal agent in dermatological practice but not one clearly associated with erythema nodosum. There is only one published report in 2014 that described a delayed onset of erythema nodosum after cholestasis complicated terbinafine therapy. We report the case of a woman who developed erythema nodosum whilst on terbinafine therapy for onychomycosis to further consider this link and its potential implications.
Authors and Affiliations
Raghu Vasanthan, Patrick D Mahar, Irene Grigoris, Esther Myint
Keywords
Related Articles
- EP ID EP713832
- DOI https://doi.org/10.46889/JDR.2023.4104
- Views 23
- Downloads 0
Severe Sunburn as the Overwhelming Risk Factor for 3 Common Skin Cancers: New Prevention Strategy
Re-analysis of published data from two large prospective cohort studies by Wu et al provides hitherto most unequivocal evidence showing Severe Sunburn (SS) as an overwhelming risk factor (> 90%) for all incidences of m...
Cutaneous Loxoscelism On 5 Moroccan Cases
Introduction: Loxoscelism is an under-diagnosed condition due to lack of awareness among practitioners. It is a serious form of araneism that can be strictly cutaneous with variable clinical aspects that can be deadly....
In An Incisional Model of Wound Healing, Genistein Aglycone Enhances Skin Recovery: A Comparison with Raloxifene and Estradiol in Ovariectomized Rats Is Presented
Context and goal: Poor wound healing is commonly associated with estrogen depletion during menopause. Experiments on anti-aging cosmetic formulations using genistein have yielded intriguing findings about skin health. He...
A Naevus Sebaceous with Tumour of the Follicular Infundibulum, Trichilemmoma, Desmoplastic Trichilemmoma, Apocrine Adenoma and Syringocystadenoma Papilliferum: Report of a Case
Nevus Sebaceous of Jadasson (SNJ) has been reported with various coexisting benign and rarely with malignant neoplasms. We present a case of SNJ with five benign epidermal and adnexal neoplasms, some of them with unusu...
Upadacitinib Efficacy for the Treatment of Concomitant Psoriasis and Alopecia Areata
Upadacitinib is a selective JAK-1 inhibitor initially approved for the treatment of rheumatoid arthritis and recently psoriatic arthritis (PsA). We present a patient with Atopic Dermatitis (AD), Psoriasis (PsO), PsA and...